About

At a glance International reach Meet some of our global team EMERTON way of impact

Functional expertise

Strategy M&A support Marketing & Sales Digital transformation Data & AI Innovation Economics & Regulation Performance & Transformation

Healthcare

Expertise Featured Experts Featured Projects

Industries

Energy Industry Aerospace Mobility Consumer TMT Healthcare

Join Emerton

Who we look for Recruitment process Career track and personal development

Expertise

Featured Experts

Matthias Tim Wartenberg

Partner

Expertise

Biotech
Digital healthcare
Medtech
Pharmaceuticals

Steffen Krause

Partner

Expertise

Biotech
Digital healthcare
Healthcare services
Pharmaceuticals

Dan Dannenberg

Partner

Expertise

Medical diagnostics
Medtech

François De Leo

Associate Partner

Expertise

Digital healthcare
Medtech
Nuclear medecine
Pharmaceuticals

The pipeline of therapeutic radiopharmaceuticals is growing and several clinical stage drugs have recently entered the market. These new therapies offer the potential to upset the oncology landscape by establishing therapeutic radiopharmaceuticals as a tool in the arsenal against cancer.

Nuclear medicine makes its way into the therapeutic arsenal against cancer

Perspectives

Featured Projects

International expansion strategy for market-leading U.S. surgical products company

1. Understanding of strategic and operational context
  • This market-leading U.S. surgical products company was struggling to generate growth against the backdrop of an aging portfolio and strong competition from low-cost Asian competitors
  • Members of the Emerton team were engaged to identify and prioritize new growth opportunities in the relatively untapped markets of Europe and Latin America
  • The team worked directly with the CEO to prioritize markets and develop country-specific strategies that led to new growth
2. Market opportunity assessment
  • Ranking of country-specific markets based upon market size, profitability, and relative competitive intensity
  • Detailed assessment of customer needs and competitive environment to develop winning sales and marketing strategies that leveraged existing portfolio
3. Competitive assessment
  • Market-by-market assessment of key competitors: market share, resource allocations, and product / service positioning
  • Identification of product and service gaps vis-à-vis key competitors to identify opportunities to improve competitiveness
4. Corporate and business unity strategy
  • Five-year strategic plan for generating double digit annual growth
  • Market-by-market tactical recommendations and performance goals
  • Comprehensive business plan with detailed roles and responsibilities

Market opportunity assessment and out-licensing transaction support for British developer of central nervous systems therapeutic

1. Understanding of strategic and operational context
  • Client’s market-leading central nervous system therapeutic had enabled it to develop a strong foothold in Europe and the U.S.
  • Company needed new sources of funding to fuel ongoing business expansion in core markets but wanted to maintain long-term option to expand in Asia-Pacific
  • Management asked members of Emerton team to develop Japan licensing strategy that maximized near-term cashflow while positioning the company for future success for a stronger direct presence in Asia-Pacific
2. Market opportunity assessment
  • Review of patient populations and epidemiology
  • Review of clinical practice and treatment paradigms
  • Competitive assessment and resource benchmarking
  • Revenue forecasting and business case development
3. Partner identification and prioritization
  • Identification and prioritization of highest potential partners
  • Intelligence gathering to understand overall competitive positioning, anticipate needs, and assess the partnering track record for high potential licensees
4. Pitch development
  • Development of pitch materials and data room
  • Customization of materials and approach to better fit the specific needs of each targeted partner
  • Engagement with key opinion leading physicians to strengthen position and reinforce attractiveness of business case
5. Transaction support
  • Value sharing analysis
  • Competitive deal benchmarking
  • Supplementary data gathering to support ongoing Q&A
  • Expert opinion and presentation support
6. Results
  • Successful execution of Japan-only licensing deal
  • Attractive valuation that provided funding for expansion in core markets
  • Flexible deal terms and value sharing arrangement that enabled client to gradually build local presence and maintain options for the future

Policy guideline development and advocacy to support launch of new class of medical technology

1. Understanding of strategic and operational context
  • Major healthcare system under pressure to rapidly develop policy guidelines to support evolution of new medical technology that would reduce systemwide costs while improving patient and caregiver safety
  • Technology represented a significant threat to entrenched players who were vocally resistant to policy change
  • Guidelines had to be well-researched and socialized to address concerns of multiple-stakeholders and ensure support
2. Stakeholder needs assessment
  • Identification of key stakeholders, needs, and concerns
  • Development of target list of key issues and questions to be researched, addressed, and incorporated as part of final recommendations
  • Recruitment of key opinion leaders to support research and provide voice of authority to recommendations
3. Best practice assessment
  • Review of global regulatory precedent and experience
  • Identification of best practices and lessons learned by major regulatory systems
  • Facilitation of communication and data exchange among regulatory bodies in Europe, North America and Japan
4. Draft policy guidelines
  • Synthesis of recommendations into draft policy guidelines
  • Assistance with socialization of guidelines and editing of documentation to incorporate feedback
5. Impact assessment
  • Qualitative and quantitative assessment of policy impact
6. Implementation support
  • Feedback on final policy guidelines
  • Support with presentations and public questions and answers